Bio-Techne
Supplies protein reagents, analysis instruments, spatial assays, and diagnostic controls.
$72.36
After-hours close+0.01 (+0.01%)
At close$72.35(−0.17%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 121.00%Insiders 0.33%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 156.57M · Float 155.94M · 99.6% free float
Institutions13F, as of Jun 30, 2026
612 holders · 189.44M shares · 131 new positions · 294 increased · 242 reduced · 121 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.03M | 8.96% | +1.76M | Aug 7, 2026 |
| FMR LLC | 12.79M | 8.17% | +4.89M | Aug 13, 2026 |
| Vanguard Capital Management LLC | 10.22M | 6.53% | +38.8K | Aug 13, 2026 |
| Goldman Sachs Group Inc | 7.34M | 4.69% | +5.40M | Aug 14, 2026 |
| HBK Investments L P | 6.83M | 4.36% | +6.83Mnew | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 6.51M | 4.16% | +26.0K | Aug 13, 2026 |
| Morgan Stanley | 6.37M | 4.07% | −2.16M | Aug 13, 2026 |
| State Street Corp | 5.98M | 3.82% | +112.0K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.38% | 11.56M | 13G | Apr 29, 2026 ↗ |
| BlackRock, Inc. | 7.00% | 11.01M | 13G | Jul 16, 2025 ↗ |
| FMR LLC | 5.00% | 7.86M | 13G | May 6, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| James Hippel | officer: CFO | 170.2K | 0.11% | Aug 18, 2026 |
| Kim Kelderman | director, officer: Chief Executive Officer | 82.8K | 0.05% | Aug 18, 2026 |
| John L. Higgins | director | 66.9K | 0.04% | Nov 3, 2025 |
| Robert V. Baumgartner | director | 46.5K | 0.03% | Nov 3, 2025 |
| Roeland Nusse | director | 44.6K | 0.03% | Aug 27, 2025 |
| William Geist | officer: PRESIDENT, PROTEIN SCIENCES | 24.9K | 0.02% | Aug 18, 2026 |
| Joseph D. Keegan | director | 15.4K | 0.01% | Nov 3, 2025 |
| Alpna Seth | director | 15.4K | 0.01% | Nov 3, 2025 |
| Rupert Vessey | director | 11.0K | 0.01% | Nov 3, 2025 |
| Shane Bohnen | officer: SVP - General Counsel | 10.4K | 0.01% | Aug 18, 2026 |
15 people have not refiled in the last 18 months (6.57M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 8, 2026 | Amy E. Herrdirector | Sale | 6,636 | $48.28 | 200 |
| Feb 17, 2026 | Amy E. Herrdirector | Sale | 1,976 | $59.11 | 200 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. April Delaney · MD06 | Sale | $1,001 – $15,000 | Apr 8, 2026 | May 7, 2026 ↗ | |
| Rep. April Delaney · MD06 | Sale | $1,001 – $15,000 | Mar 26, 2026 | Apr 8, 2026 ↗ |